HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.

AuthorsJon Wadsley, Gemma Ainsworth, Amy Beth Coulson, Kate Garcez, Laura Moss, Kate Newbold, Kate Farnell, Jayne Swain, Helen Howard, Matthew Beasley, Andrew Weaver, Katie Wood, Jennifer Marshall, Matthew Griffin, Abigail Pascoe, Yong Du, Jan Taprogge, Glenn Flux, Sarah Brown
JournalThyroid : official journal of the American Thyroid Association (Thyroid) Vol. 33 Issue 9 Pg. 1119-1123 (09 2023) ISSN: 1557-9077 [Electronic] United States
PMID37565288 (Publication Type: Clinical Trial, Phase II, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Iodine Radioisotopes
  • Iodine
  • Antineoplastic Agents
Topics
  • Humans
  • Iodine Radioisotopes (therapeutic use)
  • Iodine (therapeutic use)
  • Thyroid Neoplasms (radiotherapy, drug therapy)
  • Adenocarcinoma
  • Antineoplastic Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: